539 related articles for article (PubMed ID: 9350579)
1. Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994.
Dong W; Colhoun HM; Poulter NR
J Hypertens; 1997 Oct; 15(10):1063-8. PubMed ID: 9350579
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive use and blood pressure in a German metropolitan population.
Cairns V; Keil U; Doering A; Koenig W; Stieber J; Kleinbaum DG
Int J Epidemiol; 1985 Sep; 14(3):389-95. PubMed ID: 3877006
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure changes and hormonal contraceptives.
Shen Q; Lin D; Jiang X; Li H; Zhang Z
Contraception; 1994 Aug; 50(2):131-41. PubMed ID: 7956212
[TBL] [Abstract][Full Text] [Related]
4. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
6. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.
Straznicky NE; Barrington VE; Branley P; Louis WJ
J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure and contraceptive use.
Khaw KT; Peart WS
Br Med J (Clin Res Ed); 1982 Aug; 285(6339):403-7. PubMed ID: 6809102
[TBL] [Abstract][Full Text] [Related]
8. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
Lidegaard O
BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
[TBL] [Abstract][Full Text] [Related]
9. A population study on the relationship between blood pressure and the excretion of urinary cations.
Staessen J; Fagard R; Lijnen P; Amery A
J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S210-4. PubMed ID: 6204144
[TBL] [Abstract][Full Text] [Related]
10. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Wilson ES; Cruickshank J; McMaster M; Weir RJ
Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure changes and oral contraceptive use: a study of 2676 black women in the southeastern United States.
Blumenstein BA; Douglas MB; Hall WD
Am J Epidemiol; 1980 Oct; 112(4):539-52. PubMed ID: 7424902
[TBL] [Abstract][Full Text] [Related]
12. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
Heinemann LA; Lewis MA; Thorogood M; Spitzer WO; Guggenmoos-Holzmann I; Bruppacher R
BMJ; 1997 Dec; 315(7121):1502-4. PubMed ID: 9420491
[TBL] [Abstract][Full Text] [Related]
13. Latest views on pill prescribing.
Kay CR
J R Coll Gen Pract; 1984 Nov; 34(268):611-4. PubMed ID: 6502571
[TBL] [Abstract][Full Text] [Related]
14. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
15. Low-dose oral contraception and blood pressure in women with a past history of elevated blood pressure.
Tsai CC; Williamson HO; Kirkland BH; Braun JO; Lam CF
Am J Obstet Gynecol; 1985 Jan; 151(1):28-32. PubMed ID: 3966503
[TBL] [Abstract][Full Text] [Related]
16. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives and myocardial infarction: results of the MICA case-control study.
Dunn N; Thorogood M; Faragher B; de Caestecker L; MacDonald TM; McCollum C; Thomas S; Mann R
BMJ; 1999 Jun; 318(7198):1579-83. PubMed ID: 10364115
[TBL] [Abstract][Full Text] [Related]
18. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
19. Use of oral contraceptives and serum beta-carotene.
Berg G; Kohlmeier L; Brenner H
Eur J Clin Nutr; 1997 Mar; 51(3):181-7. PubMed ID: 9076409
[TBL] [Abstract][Full Text] [Related]
20. An epidemiological study of the haemostatic and other effects of oral contraceptives.
Meade TW; Brozović M; Chakrabarth R; Howarth DJ; North WR; Stirling Y
Br J Haematol; 1976 Nov; 34(3):353-64. PubMed ID: 990177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
